Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study

Objective To characterize the epidemiological characteristics of malignancy in Chinese patients with rheumatoid arthritis (RA) versus American patients and investigate their associated factors. Methods Data were collected from a real-world Chinese RA population and American patients with RA from the...

Full description

Bibliographic Details
Main Authors: Zhi-Ming Ouyang, Yao-Wei Zou, Jie Pan, Ye Lu, Ying Yang, Qian-Hua Li, Jian-Da Ma, Pei-Wen Jia, Tao Wu, Yu-Ting Fan, Jian-Zi Lin, Xiu-Ning Wei, Kui-Min Yang, Yun Su, Lie Dai
Format: Article
Language:English
Published: PeerJ Inc. 2024-12-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/18650.pdf
_version_ 1826926104924913664
author Zhi-Ming Ouyang
Yao-Wei Zou
Jie Pan
Ye Lu
Ying Yang
Qian-Hua Li
Jian-Da Ma
Pei-Wen Jia
Tao Wu
Yu-Ting Fan
Jian-Zi Lin
Xiu-Ning Wei
Kui-Min Yang
Yun Su
Lie Dai
author_facet Zhi-Ming Ouyang
Yao-Wei Zou
Jie Pan
Ye Lu
Ying Yang
Qian-Hua Li
Jian-Da Ma
Pei-Wen Jia
Tao Wu
Yu-Ting Fan
Jian-Zi Lin
Xiu-Ning Wei
Kui-Min Yang
Yun Su
Lie Dai
author_sort Zhi-Ming Ouyang
collection DOAJ
description Objective To characterize the epidemiological characteristics of malignancy in Chinese patients with rheumatoid arthritis (RA) versus American patients and investigate their associated factors. Methods Data were collected from a real-world Chinese RA population and American patients with RA from the National Health and Nutritional Examination Survey. The prevalence and subtypes of malignancy and their potential associated factors were investigated in both populations. Results A total of 2,073 Chinese and 2,928 American patients with RA were included. There was a lower prevalence of malignancy in Chinese than in their American counterparts before (5.7% vs. 17.1%) and after matching (6.2% vs. 12.6%, both P < 0.001). Gender discrepancies in malignancy prevalence were observed, with a male predilection for RA with malignancy in China (8.2% vs. 5.5%), while it was the opposite in American patients (10.1% vs. 13.5%, both P < 0.05). The top type of malignancy among male patients with RA was lung cancer in Chinese (2.29%), but non-melanoma skin cancer (3.43%) in American; while among female patients was breast cancer both in Chinese (1.72%) and American (3.43%). Multivariate logistic regression analyses showed that older age (odds ratio (OR) = 1.050) and positive anti-cyclic citrullinated peptide antibody (OR = 2.752) were independently associated with malignancy in Chinese patients with RA, while female (OR = 1.395), older age (OR = 1.033), active smoking (OR = 1.580) and cardiovascular diseases (OR = 1.523) in American patients. Conclusion The prevalence, subtypes and risk factors of malignancy were substantially different in Chinese patients with RA and their American counterparts, which implied the importance of individualized malignancy screening strategies for patients with RA.
first_indexed 2025-02-17T15:05:59Z
format Article
id doaj.art-fc6d69279e2b49b4843fef8a4df1b2e7
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2025-02-17T15:05:59Z
publishDate 2024-12-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-fc6d69279e2b49b4843fef8a4df1b2e72024-12-20T15:05:10ZengPeerJ Inc.PeerJ2167-83592024-12-0112e1865010.7717/peerj.18650Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative studyZhi-Ming Ouyang0Yao-Wei Zou1Jie Pan2Ye Lu3Ying Yang4Qian-Hua Li5Jian-Da Ma6Pei-Wen Jia7Tao Wu8Yu-Ting Fan9Jian-Zi Lin10Xiu-Ning Wei11Kui-Min Yang12Yun Su13Lie Dai14Department of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaZhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaObjective To characterize the epidemiological characteristics of malignancy in Chinese patients with rheumatoid arthritis (RA) versus American patients and investigate their associated factors. Methods Data were collected from a real-world Chinese RA population and American patients with RA from the National Health and Nutritional Examination Survey. The prevalence and subtypes of malignancy and their potential associated factors were investigated in both populations. Results A total of 2,073 Chinese and 2,928 American patients with RA were included. There was a lower prevalence of malignancy in Chinese than in their American counterparts before (5.7% vs. 17.1%) and after matching (6.2% vs. 12.6%, both P < 0.001). Gender discrepancies in malignancy prevalence were observed, with a male predilection for RA with malignancy in China (8.2% vs. 5.5%), while it was the opposite in American patients (10.1% vs. 13.5%, both P < 0.05). The top type of malignancy among male patients with RA was lung cancer in Chinese (2.29%), but non-melanoma skin cancer (3.43%) in American; while among female patients was breast cancer both in Chinese (1.72%) and American (3.43%). Multivariate logistic regression analyses showed that older age (odds ratio (OR) = 1.050) and positive anti-cyclic citrullinated peptide antibody (OR = 2.752) were independently associated with malignancy in Chinese patients with RA, while female (OR = 1.395), older age (OR = 1.033), active smoking (OR = 1.580) and cardiovascular diseases (OR = 1.523) in American patients. Conclusion The prevalence, subtypes and risk factors of malignancy were substantially different in Chinese patients with RA and their American counterparts, which implied the importance of individualized malignancy screening strategies for patients with RA.https://peerj.com/articles/18650.pdfRheumatoid arthritisMalignancyChineseAmerican
spellingShingle Zhi-Ming Ouyang
Yao-Wei Zou
Jie Pan
Ye Lu
Ying Yang
Qian-Hua Li
Jian-Da Ma
Pei-Wen Jia
Tao Wu
Yu-Ting Fan
Jian-Zi Lin
Xiu-Ning Wei
Kui-Min Yang
Yun Su
Lie Dai
Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
PeerJ
Rheumatoid arthritis
Malignancy
Chinese
American
title Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
title_full Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
title_fullStr Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
title_full_unstemmed Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
title_short Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis: a comparative study
title_sort different prevalence and spectrum of malignancy between chinese patients and american patients with rheumatoid arthritis a comparative study
topic Rheumatoid arthritis
Malignancy
Chinese
American
url https://peerj.com/articles/18650.pdf
work_keys_str_mv AT zhimingouyang differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT yaoweizou differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT jiepan differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT yelu differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT yingyang differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT qianhuali differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT jiandama differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT peiwenjia differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT taowu differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT yutingfan differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT jianzilin differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT xiuningwei differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT kuiminyang differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT yunsu differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy
AT liedai differentprevalenceandspectrumofmalignancybetweenchinesepatientsandamericanpatientswithrheumatoidarthritisacomparativestudy